135 related articles for article (PubMed ID: 34997668)
1. Dynamic susceptibility contrast and diffusion-weighted MRI in posterior fossa pilocytic astrocytoma and medulloblastoma.
Kurokawa R; Umemura Y; Capizzano A; Kurokawa M; Baba A; Holmes A; Kim J; Ota Y; Srinivasan A; Moritani T
J Neuroimaging; 2022 May; 32(3):511-520. PubMed ID: 34997668
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI.
Kurokawa R; Kurokawa M; Baba A; Kim J; Capizzano A; Bapuraj J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Nov; 101(44):e31708. PubMed ID: 36343086
[TBL] [Abstract][Full Text] [Related]
3. Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
Kurokawa R; Kurokawa M; Baba A; Kim J; Srinivasan A; Moritani T
PLoS One; 2023; 18(7):e0288412. PubMed ID: 37450487
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis of Apparent Diffusion Coefficient in Pediatric Medulloblastoma, Ependymoma, and Pilocytic Astrocytoma.
Dury RJ; Lourdusamy A; Macarthur DC; Peet AC; Auer DP; Grundy RG; Dineen RA
J Magn Reson Imaging; 2022 Jul; 56(1):147-157. PubMed ID: 34842328
[TBL] [Abstract][Full Text] [Related]
5. Intracranial paragangliomas versus schwannomas: Role of dynamic susceptibility contrast perfusion and diffusion MRI.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
J Neuroimaging; 2022 Sep; 32(5):875-883. PubMed ID: 35562184
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Cerebellar Hemisphere Tumors: Combining Apparent Diffusion Coefficient Histogram Analysis and Structural MRI Features.
Payabvash S; Tihan T; Cha S
J Neuroimaging; 2018 Nov; 28(6):656-665. PubMed ID: 30066449
[TBL] [Abstract][Full Text] [Related]
7. Diffusion MRI in Evaluation of Pediatric Posterior Fossa Tumors.
Phuttharak W; Wannasarnmetha M; Wara-Asawapati S; Yuthawong S
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1129-1136. PubMed ID: 33906305
[TBL] [Abstract][Full Text] [Related]
8. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
9. Application of Apparent Diffusion Coefficient Histogram Metrics for Differentiation of Pediatric Posterior Fossa Tumors : A Large Retrospective Study and Brief Review of Literature.
Gonçalves FG; Zandifar A; Ub Kim JD; Tierradentro-García LO; Ghosh A; Khrichenko D; Andronikou S; Vossough A
Clin Neuroradiol; 2022 Dec; 32(4):1097-1108. PubMed ID: 35674799
[TBL] [Abstract][Full Text] [Related]
10. MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.
Pons-Escoda A; Garcia-Ruiz A; Garcia-Hidalgo C; Gil-Solsona R; Naval-Baudin P; Martin-Noguerol T; Fernandez-Coello A; Flores-Casaperalta S; Fernandez-Viñas M; Gago-Ferrero P; Oleaga L; Perez-Lopez R; Majos C
Eur Radiol; 2023 Dec; 33(12):9120-9129. PubMed ID: 37439938
[TBL] [Abstract][Full Text] [Related]
11. The impact of ADC-histogram parameters on the discrimina-tion between medulloblastoma, ependymoma, and pilocytic astrocytoma.
Minh Duc N
Clin Ter; 2022; 173(4):369-376. PubMed ID: 35857056
[TBL] [Abstract][Full Text] [Related]
12. Histogram Analysis of Diffusion Tensor Imaging Parameters in Pediatric Cerebellar Tumors.
Wagner MW; Narayan AK; Bosemani T; Huisman TA; Poretti A
J Neuroimaging; 2016 May; 26(3):360-5. PubMed ID: 26331360
[TBL] [Abstract][Full Text] [Related]
13. Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.
Kurokawa R; Kurokawa M; Baba A; Ota Y; Kim J; Capizzano A; Srinivasan A; Moritani T
Eur Radiol; 2022 Jun; 32(6):3672-3682. PubMed ID: 35022811
[TBL] [Abstract][Full Text] [Related]
14. Volumetric voxelwise apparent diffusion coefficient histogram analysis for differentiation of the fourth ventricular tumors.
Payabvash S; Tihan T; Cha S
Neuroradiol J; 2018 Dec; 31(6):554-564. PubMed ID: 30230411
[TBL] [Abstract][Full Text] [Related]
15. Use of Apparent Diffusion Coefficient Histogram in Differentiating Between Medulloblastoma and Pilocytic Astrocytoma in Children.
Wang W; Cheng J; Zhang Y; Wang C
Med Sci Monit; 2018 Sep; 24():6107-6112. PubMed ID: 30173245
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of pilocytic and pilomyxoid astrocytomas using dynamic susceptibility contrast perfusion and diffusion weighted imaging.
Ho CY; Supakul N; Patel PU; Seit V; Groswald M; Cardinal J; Lin C; Kralik SF
Neuroradiology; 2020 Jan; 62(1):81-88. PubMed ID: 31676961
[TBL] [Abstract][Full Text] [Related]
17. The performance of diffusion tensor imaging parameters for the distinction between medulloblastoma and pilocytic astrocytoma.
Minh Duc N
Minerva Pediatr (Torino); 2024 Apr; 76(2):201-207. PubMed ID: 33820409
[TBL] [Abstract][Full Text] [Related]
18. Perfusion and diffusion-weighted imaging parameters: Comparison between pre- and postbiopsy MRI for high-grade glioma.
Kurokawa R; Baba A; Kurokawa M; Capizzano A; Ota Y; Kim J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Sep; 101(35):e30183. PubMed ID: 36107564
[TBL] [Abstract][Full Text] [Related]
19. Advantage of high b value diffusion-weighted imaging for differentiation of common pediatric brain tumors in posterior fossa.
Takeishi Y; Takayasu T; Kolakshyapati M; Yonezawa U; Amatya VJ; Takano M; Taguchi A; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
Eur J Radiol; 2020 Jul; 128():108983. PubMed ID: 32438259
[TBL] [Abstract][Full Text] [Related]
20. Brain Perfusion and Diffusion Abnormalities in Children Treated for Posterior Fossa Brain Tumors.
Li MD; Forkert ND; Kundu P; Ambler C; Lober RM; Burns TC; Barnes PD; Gibbs IC; Grant GA; Fisher PG; Cheshier SH; Campen CJ; Monje M; Yeom KW
J Pediatr; 2017 Jun; 185():173-180.e3. PubMed ID: 28187964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
